T0	Participants 102 139	patients with advanced solid tumours:
T1	Participants 503 539	Patients with advanced solid tumours
T2	Participants 852 887	Twenty-seven patients were treated;
T3	Participants 1235 1244	detected.
T4	Participants 1245 1285	Four patients achieved partial responses